Wave Life Sciences (NASDAQ:WVE) filed its quarterly report for the period ended Sept. 30 on Tuesday. The clinical-stage biotechnology company develops RNA medicines on its PRISM platform, which combines RNA interference, RNA editing, antisense silencing and splicing modalities.
Xylem (NYSE:XYL) reported third quarter 2026 results on Tuesday. Revenue was USD 2,201 million, compared with USD 2,268 million, and flat organically. Management attributed the flat revenue to project timing and a more cautious, deliberate utility spending environment. Orders rose 10% organically to USD …
Zura Bio (NASDAQ:ZURA), a clinical-stage biotech company developing medicines for autoimmune and inflammatory diseases, filed its quarterly report for the period ended Sept. 30 on Tuesday. Total operating expenses were USD 28.8 million, compared with USD 19.5 million. Research and development expense rose 63%, …
Alkami Technology (NASDAQ:ALKT) reports third-quarter results on Wednesday, Oct. 28, after the market closes. Consensus stands at EPS of 0.20 on revenue of USD 133.54 million, and the company has a market capitalization of USD 1.68 billion.
Alerus Financial (NASDAQ:ALRS) reports third-quarter results on Wednesday, Oct. 28, with the timing not given in the estimates table. Consensus stands at EPS of 0.66 on revenue of USD 76.72 million, and the company has a market capitalization of USD 810.64 million.
Aurora Innovation (NASDAQ:AUR) reports third-quarter results on Wednesday, Oct. 28, after the market closes. Consensus stands at EPS of -0.12 on revenue of USD 2.99 million, and the company has a market capitalization of USD 9.76 billion.
Benchmark Electronics (NYSE:BHE) reports third-quarter results on Wednesday, Oct. 28, after the market closes. Consensus stands at EPS of 0.79 on revenue of USD 776.65 million, and the company has a market capitalization of USD 2.40 billion.
Century Communities (NYSE:CCS) reports third-quarter results on Wednesday, Oct. 28, after the market closes. Consensus stands at EPS of 1.20 on revenue of USD 949.83 million, and the company has a market capitalization of USD 1.63 billion.
Columbia Financial (NASDAQ:CLBK) reports third-quarter results on Wednesday, Oct. 28, with the timing not given in the estimates table. Consensus stands at EPS of 0.15 on revenue of USD 129.93 million, and the company has a market capitalization of USD 2.94 billion.
Climb Global Solutions (NASDAQ:CLMB) reports third-quarter results on Wednesday, Oct. 28, with the timing not given in the estimates table. Consensus stands at EPS of 0.38 on revenue of USD 180.98 million, and the company has a market capitalization of USD 613.00 million.